Emerging Biomarkers and Metabolomics for Assessing Toxic Nephropathy and Acute Kidney Injury (AKI) in Neonatology

Por Mussap, M., Noto, A., Fanos, V., Van Den Anker, J. N.
Publicado em 2014

Antifungal agents in neonatal systemic candidiasis.

Por van den Anker, J N, van Popele, N M, Sauer, P J
Publicado em 1995

Randomised controlled trial evaluating effects of morphine on plasma adrenaline/noradrenaline concentrations in newborns

Por Simons, S, van Dijk, M, van Lingen, R A, Roofthooft, D, Boomsma, F, van den Anker, J N, Tibboel, D
Publicado em 2005

Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks.

Por Huisman-de Boer, J J, van den Anker, J N, Vogel, M, Goessens, W H, Schoemaker, R C, de Groot, R
Publicado em 1995

Pharmacokinetics and metabolism of oral midazolam in preterm infants

Por de Wildt, S N, Kearns, G L, Hop, W C J, Murry, D J, Abdel-Rahman, S M, van den Anker, J N
Publicado em 2002

Once-daily versus twice-daily administration of ceftazidime in the preterm infant.

Por van den Anker, J N, Schoemaker, R C, van der Heijden, B J, Broerse, H M, Neijens, H J, de Groot, R
Publicado em 1995

Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin.

Por van den Anker, J N, Hop, W C, Schoemaker, R C, van der Heijden, B J, Neijens, H J, de Groot, R
Publicado em 1995

Morphine in ventilated neonates: its effects on arterial blood pressure

Por Simons, S H P, Roofthooft, D W E, van Dijk, M, van Lingen, R A, Duivenvoorden, H J, van den Anker, J N, Tibboel, D
Publicado em 2006

Respiratory illness in families of preterm infants with chronic lung disease.

Por de Winter, J. P., van Sonderen, L., van den Anker, J. N., Merth, I. T., Brand, R., van Bel, F., Zonderland, H. M., Quanjer, P. H.
Publicado em 1995